Your current web browser is outdated. For best viewing experience, please consider upgrading to the latest version.

Contact

Send a question or comment using the form below. This message may be routed through support staff.

Email Article

ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed
OKAY
ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed
CANCEL CONFIRM

Manhattan Institute

search
Close Nav

Search

Close Search
search

Health Policy - Drug Development

ALL TOPICS

Health Policy

Drug Development

The U.S. is the world's leader in biopharmaceutical innovation, mainly because it does not impose price controls on prescription drugs. The Manhattan Institute is dedicated to the development of market-based policy alternatives to sustain medical progress and promote medical innovation.

Experts
Chris
Pope
Tom
Coburn
Peter W.
Huber
INQUIRIES

Media:

For interviews, please contact interview@manhattan-institute.org

 

Multimedia
Video

Severe Mental Illness: Are Policies Helping or Hurting Those in Need?
  • DJ Jaffe
  • May 11, 2018
  • Health PolicyMental Illness
Past Events

Bring Back The Asylum?

Tuesday, May. 8, 2018

FDA Regulation In An Era of Precision Medicine

Thursday, December. 14, 2017

See All

FEATURED BOOK

New York's Next Health Care Revolution

WHAT WILL OBAMACARE COST YOU?

Obamacare Impact Map

Publications

0
Sort by Date
Expand Contract
Filters
Clear all
Sorry we were unable to find any results for “”
Search suggestions
  • Make sure words are spelled correctly.
  • Try entering different keywords.
  • Try using more general keywords.
  • Try fewer keywords.
Loading
Load More
Saved!
Close